跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
ACH-SITAGLIPTIN
Authorized
STANDARD
ACH-SITAGLIPTIN
Accord Healthcare Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
fc8ae9bc65553f3a
Company
Accord Healthcare Inc
Type
Standard
Approval Details
Approval Id
fc8ae9bc65553f3a
Drug Approval Canada Name
ACH-SITAGLIPTIN
Product Name
ACH-SITAGLIPTIN
Status
Marketed
Status Date
2023-05-12
Original Market Date
2023-05-12
Din
02512483
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:20.05
Atc Original
A10BH01 SITAGLIPTIN
Atc Name
a 10 bh 01
Aig Number
0152414003
Company Name
Accord Healthcare Inc
Company Address
3535 Boulevard St-Charles, Suite 704, Kirkland, Quebec, Canada, H9H 5B9
Company Detail Path
/organization/accord-healthcare-inc
Company Information
Pharmaceutical Company Name
Accord Healthcare Inc
Country Name
Canada
Province Name
Quebec
City Name
kirkland,quebec,country_ca
Address
704-3535 boul Saint-Charles
Active Ingredients
SITAGLIPTIN (SITAGLIPTIN PHOSPHATE)
50 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
fc8ae9bc65553f3a
Type
Standard
Back to Health Canada Approvals
ACH-SITAGLIPTIN - Health Canada Drug Approval Details